Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q1 | Apr 15, 2024 | Palm Harbour Capital | 5.1% | 13.5% | 1952.T, 9404.T, ALL.AX, CIR.MI, EVRI, FDJ.PA, FLTR.L, HAT.L, IGT, LNW, OCWN, OPAP.AT, PBL.TO, PPA.AT, SYENS.BR, TISG.MI | Buybacks, dividends, Europe, gaming, Media, Ports, small caps, value | Portfolio trades at weighted average P/E of 8.9x with 17% FCF/EV yield and 28% return on tangible capital. Manager believes portfolio has more than 101% upside to estimated NAV. Focus on undervalued companies with strong cash generation and balance sheet efficiency opportunities. | IGT |
View |
| 2023 Q4 | Dec 31, 2023 | Meridian Small Cap Growth Fund | 6.2% | 0.0% | ALIT, CARG, CCCC, CCSI, EVRI, HDSN, MATX, MIR, QDEL, RBA, SKIN, SONX, TPB | Biotechnology, gaming, growth, healthcare, small cap, technology, value | The fund holds C4 Therapeutics, a biotechnology firm specializing in protein degradation therapies for cancer treatment. The company has three treatments in early-stage clinical trials targeting multiple cancers and announced a formal agreement with Merck for co-development. Positive clinical readout on a leading compound provided encouraging signals for therapeutic efficacy. | CCCC CARG MRAD |
View |
| 2024 Q2 | Nov 7, 2022 | Patient Capital Management | 5.6% | 15.8% | AAPL, AMZN, BIIB, CVS, DAL, EVRI, EXPE, GOOGL, IAC, ILMN, KOS, META, MSFT, NCLH, NVDA, RPRX, TSLA, UAL | AI, energy, healthcare, small caps, technology, Travel, value | Manager recognizes AI bubble potential but believes it may still be early. Nvidia captured bulk of AI profits with significant market lead and competitive advantages. Current AI/quality compounder momentum could get more extreme before ending. | EXPE EVRI KOS IAC NVDA |
View |
| 2024 Q3 | Oct 8, 2024 | Patient Capital Management | 5.6% | 15.8% | AAPL, AMZN, APO, EVRI, GOOGL, GXO, IBM, JPM, META, MSFT, NVDA, PLAY, QXO, RXO, TCRT, TSLA, URI, XPO | compounders, long-term, Quality, small caps, Underperformers, valuation, value | Manager emphasizes buying underperformers and exploiting opportunities where market expectations diverge from intrinsic values. Portfolio trades at significant discount to market (12x forward earnings vs 22x) with better growth prospects. Focus on attractively valued compounders, classic value, and early-stage businesses. | PLAY QXO |
View |
| 2024 Q3 | Sep 30, 2024 | Meridian Small Cap Growth Fund | 6.2% | 0.0% | AGS, BYRN, CARG, EVRI, LZ, MIR, MMSI, RBA, SEAT, SMAR, SRI, TMDX, TPB | Automotive, consumer, gaming, growth, healthcare, small caps | The fund holds Everi Holdings, a gaming technology company with hardware manufacturing and financial technology segments. The stock rose after a private equity acquisition offer at a 56% premium, reinforcing confidence in the financial technology segment. | TPB EVRI BYRN VICI LZ STRI |
View |
| 2024 Q2 | Aug 20, 2024 | Silver Ring Value Partners | 0.0% | 0.0% | ALFAA.MX, EVRI, HRL, IGT | Catalyst, Food, gaming, Intrinsic Value, Mexico, Quality, Spin-off, value | Manager emphasizes investing in genuinely attractive investments where mispricing is clear, avoiding the need to squint to see value. Portfolio trades at 60% of base case value excluding cash, with focus on businesses trading well below intrinsic value estimates. | ALFAA.MX IGT |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | Patient Capital Management | Everi Holdings Inc | Consumer Discretionary | Hotels, Restaurants & Leisure | Bull | NYSE | cash generation, Cyclical, Gaming, Hardware, merger, oligopoly, technology, Value | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Small Cap Growth Fund | Everi Holdings, Inc. | Consumer Discretionary | Hotels, Restaurants & Leisure | Bull | NYSE | 56% Premium, Cash Access, Compliance Services, Fintech, Gaming Technology, Hardware Manufacturing, Loyalty Programs, private equity acquisition | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||